(0.34%) 5 198.27 points
(0.19%) 38 926 points
(0.25%) 16 390 points
(0.59%) $78.94
(0.09%) $2.20
(-0.36%) $2 322.90
(-0.10%) $27.59
(2.53%) $989.30
(0.10%) $0.929
(0.69%) $10.90
(0.33%) $0.799
(-0.11%) $91.24
3 days till quarter result
(bmo 2024-05-10)
Expected move: +/- 4.43%
0.47% $ 121.13
Live Chart Being Loaded With Signals
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific...
Stats | |
---|---|
Dzisiejszy wolumen | 539 161 |
Średni wolumen | 1.41M |
Kapitalizacja rynkowa | 25.29B |
EPS | $0 ( 2024-04-30 ) |
Następna data zysków | ( $1.870 ) 2024-05-10 |
Last Dividend | $0.240 ( 2023-09-28 ) |
Next Dividend | $0 ( N/A ) |
P/E | 56.60 |
ATR14 | $0.0640 (0.05%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-01 | Winkler Lori | Buy | 772 | Common Stock |
2024-04-01 | Winkler Lori | Sell | 215 | Common Stock |
2024-04-01 | Winkler Lori | Sell | 772 | Restricted Stock Units |
2024-03-31 | Michelson Michael W | Buy | 207 | Phantom Stock Units |
2024-03-31 | Hilado Maria Teresa | Buy | 207 | Phantom Stock Units |
INSIDER POWER |
---|
10.08 |
Last 99 transactions |
Buy: 197 885 | Sell: 163 900 |
Wolumen Korelacja
Zimmer Biomet Holdings Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Zimmer Biomet Holdings Korelacja - Waluta/Towar
Zimmer Biomet Holdings Finanse
Annual | 2023 |
Przychody: | $7.39B |
Zysk brutto: | $4.66B (63.06 %) |
EPS: | $4.91 |
FY | 2023 |
Przychody: | $7.39B |
Zysk brutto: | $4.66B (63.06 %) |
EPS: | $4.91 |
FY | 2022 |
Przychody: | $6.94B |
Zysk brutto: | $4.92B (70.90 %) |
EPS: | $1.390 |
FY | 2021 |
Przychody: | $7.84B |
Zysk brutto: | $5.50B (70.13 %) |
EPS: | $1.930 |
Financial Reports:
No articles found.
Zimmer Biomet Holdings Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.240 (N/A) |
$0.240 (N/A) |
$0.240 (N/A) |
$0.480 (N/A) |
$0.240 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.175 | 2012-03-28 |
Last Dividend | $0.240 | 2023-09-28 |
Next Dividend | $0 | N/A |
Payout Date | 2023-10-31 | |
Next Payout Date | N/A | |
# dividends | 48 | -- |
Total Paid Out | $10.70 | -- |
Avg. Dividend % Per Year | 0.48% | -- |
Score | 4.15 | -- |
Div. Sustainability Score | 9.49 | |
Div.Growth Potential Score | 3.69 | |
Div. Directional Score | 6.59 | -- |
Year | Amount | Yield |
---|---|---|
2012 | $0.700 | 1.34% |
2013 | $0.776 | 1.18% |
2014 | $0.856 | 0.96% |
2015 | $0.856 | 0.78% |
2016 | $0.932 | 0.94% |
2017 | $0.932 | 0.93% |
2018 | $0.932 | 0.77% |
2019 | $0.932 | 0.94% |
2020 | $0.932 | 0.64% |
2021 | $0.932 | 0.63% |
2022 | $0.960 | 0.77% |
2023 | $0.960 | 0.75% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend Knight | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
ZTR | Dividend Royal | 2024-02-09 | Monthly | 37 | 8.35% | 8.50 |
PCF | Dividend King | 2023-12-18 | Monthly | 38 | 7.05% | 8.50 |
PVL | Dividend King | 2023-11-15 | Monthly | 14 | 9.37% | 8.50 |
NCV | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.68% | 8.50 |
MTR | Dividend Diamond | 2023-10-30 | Monthly | 39 | 10.10% | 8.50 |
SBR | Dividend Royal | 2023-11-14 | Monthly | 38 | 7.74% | 8.50 |
SCM | Dividend King | 2023-12-15 | Monthly | 13 | 7.08% | 8.50 |
SJT | Dividend Royal | 2023-11-29 | Monthly | 39 | 12.52% | 8.50 |
PDI | Dividend Royal | 2023-11-10 | Monthly | 13 | 7.86% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.138 | 1.500 | 7.23 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0476 | 1.200 | 8.41 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0827 | 1.500 | -0.192 | -0.289 | [0.1 - 1] |
payoutRatioTTM | 0.196 | -1.000 | 8.04 | -8.04 | [0 - 1] |
currentRatioTTM | 1.613 | 0.800 | 6.93 | 5.55 | [1 - 3] |
quickRatioTTM | 0.650 | 0.800 | -0.881 | -0.704 | [0.8 - 2.5] |
cashRatioTTM | 0.146 | 1.500 | -0.303 | -0.454 | [0.2 - 2] |
debtRatioTTM | 0.271 | -1.500 | 5.49 | -8.23 | [0 - 0.6] |
interestCoverageTTM | 6.75 | 1.000 | 8.61 | 8.61 | [3 - 30] |
operatingCashFlowPerShareTTM | 7.58 | 2.00 | 7.47 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 5.39 | 2.00 | 7.30 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.466 | -1.500 | 8.13 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.718 | 1.000 | 1.363 | 1.363 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.184 | 1.000 | 8.33 | 8.33 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.272 | 1.000 | 9.60 | 9.60 | [0.2 - 2] |
assetTurnoverTTM | 0.344 | 0.800 | -1.040 | -0.832 | [0.5 - 2] |
Total Score | 9.49 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 24.56 | 1.000 | 7.62 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0827 | 2.50 | -0.124 | -0.289 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 5.39 | 2.00 | 8.20 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.398 | 1.500 | 0.0465 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 7.58 | 2.00 | 7.47 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.196 | 1.500 | 8.04 | -8.04 | [0 - 1] |
pegRatioTTM | -0.262 | 1.500 | -5.08 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.214 | 1.000 | 7.15 | 0 | [0.1 - 0.5] |
Total Score | 3.69 |
Zimmer Biomet Holdings
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej